BeyondSpring BYSI
NASDAQ BYSI
$0.77 +0.16 (+25.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Total Current Liabilities (2015 - 2026)

BeyondSpring's (BYSI) quarterly Total Current Liabilities came in at $14.2 million in Q2 2026, up 21.0% year-over-year from $11.7 million in Q2 2025, and up 14.74% quarter-over-quarter from $12.4 million in Q1 2026.

Analysis

BeyondSpring (BYSI) Total Current Liabilities (2015 - 2026) Analysis & Trends

BeyondSpring has disclosed Total Current Liabilities across 12 years of filings, most recently posting $14.2 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities rose 21.0% year-over-year to $14.2 million; the TTM figure through Jun 2026 stood at $14.2 million (up 21.0% YoY), while the FY2025 annual figure was $13.6 million, up 23.31% from the prior year.
  • Total Current Liabilities came in at $14.2 million for Q2 2026 at BeyondSpring, up from $12.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $14.2 million in Q2 2026 to a low of $6.8 million in Q2 2023.
  • Average Total Current Liabilities over 5 years is $10.8 million, with a median of $11.4 million recorded in 2022.
  • Year-over-year, Total Current Liabilities slumped 51.49% in 2022 and soared 43.28% in 2025.
  • Over 5 years, Total Current Liabilities stood at $7.4 million in 2022, then climbed by 8.24% to $8.0 million in 2023, then surged by 38.35% to $11.0 million in 2024, then gained by 23.31% to $13.6 million in 2025, then gained by 4.54% to $14.2 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $14.2 million in Q2 2026, $12.4 million in Q1 2026, and $13.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 54.90 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 41.64 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 31.75 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 32.65 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 37.11 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 354.06 Mn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 1.31 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 607.80 Mn
10 BeyondSpring 31.51 Mn 31.51 Mn - 14.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.19 Mn
Mar 31, 2026 12.37 Mn
Dec 31, 2025 13.58 Mn
Sep 30, 2025 12.89 Mn
Jun 30, 2025 11.73 Mn
Mar 31, 2025 12.67 Mn
Dec 31, 2024 11.01 Mn
Jun 30, 2024 8.19 Mn
Dec 31, 2023 7.96 Mn
Jun 30, 2023 6.82 Mn
Dec 31, 2022 7.35 Mn
Jun 30, 2022 11.11 Mn
Dec 31, 2021 15.16 Mn
Sep 30, 2021 18.56 Mn
Jun 30, 2021 16.57 Mn
Mar 31, 2021 12.63 Mn
Dec 31, 2020 13.77 Mn
Sep 30, 2020 12.82 Mn
Jun 30, 2020 11.31 Mn
Mar 31, 2020 12.21 Mn